Studies on dialysis-related amyloid fibril formation by a in vitro kinetic model
Studies on dialysis-related amyloid fibril formation by a in vitro kinetic model
批准号:
10670992
负责人:
GEJYO Fumitake
金额:
$1.79万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Long-term dialysis is very often complicated with amyloid deposits, predominantly in articular synovial membrane. The deposition is a serious complication of dialysis as it excessively deteriorates the quality of life of long-term dialysis patients. A major component of amyloid deposits was identified as β2-microglobulin (β2-m) having a molecular weight of 11,800 daltons. The details of amyloidogenesis of this type of amyloid remain unknown. In order to consider the pathogenesis of dialysis-related amyloidoses, it is essential to elucidate the general mechanisms of amyloid fibril formation in vitro. We first developed a fluorometric method to quantifiy amyloid fibrils in vitro, using the fluorescent dye, thioflavine T. Optimum fluorescence measurements of amyloid fibrils were obtained at the excitation and emission wavelengths of about 455 nm and 485 nm, respectively, and at pH 8.5-9.0. We focused our study on the extension phase of amyloid fibril formation in vitro. When amyloid fibri … More ls were incubated with their monomeric constituent, β2-m, the extension of amyloid fibrils was observed with electron microscopy. Quantitative fluorometry revealed that extension of amyloid fibrils proceeded by a pseudo-first-order exponential increase as measured by the fluorescence of thioflavin T and the net rate of extension was the sum of the rates of polymerization and depolymerization. Then we investigated the effect of advanced glycation end product (AGE) on fAβィイD22ィエD2-m extension in vitro, using the established first-order kinetic model of fAβィイD22ィエD2-m extension in vitro. During the incubation of fAβィイD22ィエD2-m with native βィイD22ィエD2-m at 37℃, the fluorescence of thioflavin T increased without a lag phase and proceeded to equilibrium. On the contrary, only a slight increase in fluorescence was observed during the incubation of fAβィイD22ィエD2-m with AGE-βィイD22ィエD2-m. Moreover, AGE-βィイD22ィエD2-m exhibited a dose-dependent inhibitory effect on the extension reaction of fAβィイD22ィエD2-m with nativeβィイD22ィエD2-m. These results may suggest that the modification ofβィイD22ィエD2-m with AGE does not play a promoting role in the formation of fAβィイD22ィエD2-m in vivo. Less
期刊论文(69)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
下条 文武 他: "透析アミロイド関節症に対する少量ステロイド治療の現況―アンケート集計より―"日本透析医学会誌. 3. 73-78 (1998)
Fumitake Shimojo 等人:“透析淀粉样蛋白关节病低剂量类固醇治疗的现状 - 基于问卷数据”日本透析医学会杂志 3. 73-78 (1998)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
西 慎一 他: "透析アミロイドーシスの臨床症状と発症機序解明"新潟県医師会報. 592. 2-6 (1999)
Shinichi Nishi等:“透析淀粉样变性的临床症状和发病机制的阐明”新泻县医学会公报592. 2-6 (1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
下条 文武: "血液浄化療法事典(飯田喜俊、二瓶宏、秋澤忠男 編)"メディカル・サイエンス・インターナショナル(東京). 3 (1999)
Fumitake Shimojo:“血液净化疗法百科全书(由 Yoshitoshi Iida、Hiroshi Nihei 和 Tadao Akizawa 编辑)”Medical Science International(东京)3(1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
上野 光博 他: "II.疾患編 腎臓 アミロイド腎症"内科. 83・6. 1284-1288 (1999)
Mitsuhiro Ueno 等:“II. 肾脏淀粉样肾病”内科 83・6(1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
丸山 弘樹 他: "透析アミロイド-シス総論"腎と透析. 47・6. 767-711 (1999)
Hiroki Maruyama 等人:“透析淀粉样蛋白系统概述”《肾脏与透析》47・6(1999)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 67 条
The study of the mechanisms of autoimmune systemic vasculitis.
-
批准号:12670420
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:2000
-
负责人:GEJYO Fumitake
-
依托单位:
DEVELOPMENT OF MODEL MOUSE FOR DIALYSIS-RELATED AMYLOIDOSIS AND ITS APPLICATION FOR THE ANALYSIS OF PATHOGENESIS.
-
批准号:07671244
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.19万
-
财政年份:1995
-
负责人:GEJYO Fumitake
-
依托单位: